Holen Sie sich die Stockscreener-App
74.98
0.05%
-0.04
Schlusskurs vom Vortag:
$75.02
Offen:
$75
24-Stunden-Volumen:
4.14M
Relative Volume:
1.21
Marktkapitalisierung:
$16.73B
Einnahmen:
$4.04B
Nettoeinkommen (Verlust:
$557.10M
KGV:
31.11
EPS:
2.4102
Netto-Cashflow:
$916.70M
1W Leistung:
+0.15%
1M Leistung:
-0.05%
6M Leistung:
+17.41%
1J Leistung:
+7.16%
1-Tages-Spanne:
$74.91
$75.16
1-Wochen-Bereich:
$74.81
$75.17
52-Wochen-Spanne:
$51.90
$75.34
Hologic Inc Stock (HOLX) Company Profile
Firmenname
Hologic Inc
Sektor
Telefon
(508) 263-2900
Adresse
250 CAMPUS DRIVE, MARLBOROUGH, MA
Vergleichen Sie HOLX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
74.98 | 16.73B | 4.04B | 557.10M | 916.70M | 2.4102 |
|
ISRG
Intuitive Surgical Inc
|
535.00 | 191.90B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
207.11 | 59.36B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
79.00 | 39.13B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
257.58 | 38.05B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
44.12 | 33.62B | 27.43B | 1.27B | 1.01B | 1.5829 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-12 | Herabstufung | Argus | Buy → Hold |
| 2026-01-05 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-11-21 | Herabstufung | BNP Paribas Exane | Outperform → Neutral |
| 2025-10-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-08-18 | Hochstufung | Argus | Hold → Buy |
| 2025-08-06 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-05-27 | Bestätigt | Needham | Hold |
| 2025-03-03 | Herabstufung | Argus | Buy → Hold |
| 2025-02-06 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | Herabstufung | Needham | Buy → Hold |
| 2024-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-12-10 | Eingeleitet | Jefferies | Hold |
| 2024-12-10 | Bestätigt | Needham | Buy |
| 2024-10-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-06-27 | Eingeleitet | Stephens | Overweight |
| 2024-04-03 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-07-14 | Hochstufung | Needham | Hold → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-07-20 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-07-20 | Eingeleitet | UBS | Neutral |
| 2022-07-18 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2021-12-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-10-14 | Eingeleitet | Redburn | Neutral |
| 2021-07-06 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-11-20 | Herabstufung | Needham | Buy → Hold |
| 2020-11-05 | Bestätigt | Needham | Buy |
| 2020-06-30 | Hochstufung | Cowen | Market Perform → Outperform |
| 2020-06-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | Bestätigt | Needham | Buy |
| 2020-04-30 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | Bestätigt | Needham | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2020-01-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | Bestätigt | Needham | Buy |
| 2019-05-02 | Bestätigt | Needham | Buy |
| 2019-01-31 | Bestätigt | Needham | Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | Eingeleitet | UBS | Neutral |
| 2018-09-13 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Hologic Inc Aktie (HOLX) Neueste Nachrichten
How low can spreads go? Hologic’s mega LBO tests the limit - PitchBook
Bedside Breakthrough: AI Brings MRI-Precision to Every Clinic - Benzinga
Hologic wraps massive syndicated LBO loan - PitchBook
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Hologic Leads Campaign to Emphasize Routine Cervical Cancer Screening - Nasdaq
61,780 Shares in Hologic, Inc. $HOLX Purchased by Campbell & CO Investment Adviser LLC - MarketBeat
Press Release: Hologic to Announce Financial Results for the First Quarter of Fiscal 2026 on Thursday, January 29, 2026 - 富途牛牛
As Blackstone and TPG pursue Hologic deal, Q1 results arrive Jan. 29 - Stock Titan
Hologic to Announce Financial Results for the First Quarter of Fiscal 2026 on Thursday, January 29, 2026 - Barchart.com
Hologic’s $8.5 Billion LBO Loan Costs Tighten on Strong Demand - Bloomberg.com
What you need to know ahead of Hologic's earnings release - MSN
1 Healthcare Stock Worth Investigating and 2 That Underwhelm - Finviz
Hologic’s $8.5 billion LBO loan costs tighten on strong demandBloomberg News - TradingView — Track All Markets
Aug Macro: What are analysts price targets for Hologic IncEarnings Risk Summary & Reliable Price Breakout Alerts - baoquankhu1.vn
Nordea Investment Management AB Increases Stake in Hologic, Inc. $HOLX - MarketBeat
Skin Rejuvenation Devices Market Set for Rapid Expansion - openPR.com
Professional Basketball Player Erica Wheeler and Hologic Team Up to Champion Cervical Cancer ScreeningHologic, Inc. - Hologic, Inc. - Investor Relations
Body Contouring Market Top Key Players 20262035: Allergan - openPR.com
How Recent Analyst Moves Are Rewriting The Story For Hologic (NasdaqGS:HOLX) - Yahoo Finance
Argus Research Downgrades Hologic (HOLX) to Hold | HOLX Stock Ne - GuruFocus
Hologic (NASDAQ:HOLX) Downgraded by Argus to "Hold" - MarketBeat
Blackstone (BX) Involved in Hologic Acquisition Deal - GuruFocus
SG Americas Securities LLC Grows Position in Hologic, Inc. $HOLX - MarketBeat
Is Hologic Inc. stock affected by interest rate hikesPortfolio Update Summary & Daily Risk Controlled Trade Plans - Улправда
(HOLX) Risk Channels and Responsive Allocation - Stock Traders Daily
What market sentiment indicators show for Hologic Inc. (HO1) stock2025 Volatility Report & Growth Oriented Trading Recommendations - ulpravda.ru
Why Hologic Inc. stock is recommended by analystsJuly 2025 Big Picture & Fast Gain Stock Tips - ulpravda.ru
Hologic issues safety alert for breast biopsy needles - Radiology Business
Why Hologic Inc. stock appeals to analystsInflation Watch & Free Real-Time Market Sentiment Alerts - ulpravda.ru
Will Hologic Inc. (HO1) stock test record highs in 20252025 Price Targets & Verified Swing Trading Watchlists - ulpravda.ru
Why Hologic Inc. stock is seen as undervaluedJuly 2025 Drop Watch & High Accuracy Swing Entry Alerts - ulpravda.ru
Will Hologic Inc. stock outperform Dow Jones indexGlobal Markets & High Accuracy Trade Signal Alerts - ulpravda.ru
Halper Sadeh LLC Encourages HOLX, VTYX, QRVO, TEX Shareholders to Contact the Firm to Discuss Their Rights - The Malaysian Reserve
Can Hologic Inc. stock deliver surprise earnings beatMarket Trend Review & Free Risk Controlled Daily Trade Plans - ulpravda.ru
Will Hologic Inc. stock deliver consistent dividends2025 Macro Impact & Growth Focused Entry Point Reports - ulpravda.ru
Palmetto Grain Brokerage - Palmetto Grain Brokerage
What You Need To Know Ahead of Hologic's Earnings Release - Barchart.com
Hologic Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Hologic, Inc.HOLX - PR Newswire
Blackstone, TPG Deliver a $7 Billion Test to Risky Loan Market - Bloomberg.com
Assessing Hologic (HOLX) Valuation After Recent Three Month Share Price Momentum - Yahoo Finance
Is Hologic (HOLX) Pricing Look Interesting After Recent Flat Share Performance - Sahm
Is Hologic Inc. stock cheap compared to fundamentals2026 world cup usa national team round of 32 defensive leaders build up play tactical prediction statistical analysis - ulpravda.ru
Hologic downgraded to ’B+’ by S&P after take-private deal - Investing.com Nigeria
Hologic's Breast Health Unit Stays In Focus in 2026: What Lies Ahead? - The Globe and Mail
How sustainable is Hologic Inc. stock dividend payout2026 world cup usa national team semifinals young talents build up play group prediction expert opinion - ulpravda.ru
Wall Street Banks Kick Off $7 Billion Loan Sale Tied to Hologic Buyout - Bloomberg.com
Hologic Mammography Market Size to Hit USD 8.82 Billion by 2035 - Precedence Research
Diagnostic Device Market to Reach USD 79.9 Billion by 2030 | - openPR.com
Hologic Trading Near 52-Week High: How Should You Play the Stock? - Finviz
Hologic Inc. stock underperforms Thursday when compared to competitors - MSN
Hologic says 2026 CVR is more challenging with stopped shipment of product - MSN
Finanzdaten der Hologic Inc-Aktie (HOLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.07%
7.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):